Concepedia

Publication | Open Access

Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy

DOIFull Paper Access

11

Citations

17

References

2019

Year

Takaaki Tokito, Koichi Azuma, Kazuhiko Yamada, Yoshiko Naito, Norikazu Matsuo, Hidenobu Ishii, Hiroki Natori, Takashi Kinoshita, Tomoaki Hoshino
In Vivo

Abstract

We revealed that normal tumor markers levels post-CCRT in stage III NSCLC might be a useful surrogate marker for curing those patients.

References

YearCitations

Page 1